ARTICLE | Company News
MedImmune in-licenses Immune Design's adjuvant
October 27, 2010 12:02 AM UTC
Immune Design Corp. (Seattle, Wash.) granted MedImmune LLC exclusive, worldwide rights to develop and commercialize its glucopyranosyl lipid adjuvant (GLA) as a component in vaccines for undisclosed i...